Citations (118)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jens Watzlawik, Arthur E Warrington & Moses Rodriguez. (2010) Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination. Expert Review of Neurotherapeutics 10:3, pages 441-457.
Read now
Read now
Anthony R White, Nichole S Dutton & Robert D Cook. (2002) Isolation and growth of a cytopathic agent from multiple sclerosis brain tissue. Journal of Neurovirology 8:2, pages 111-121.
Read now
Read now
Henry C. Powell, Robert S. Garrett, Atis Muehlenbachs, Francesca M. Brett, Iain L. Campbell. (1999) Crystalloid Inclusions in Brain Macrophages and Hemopoietic Tissue in GFAP-IL3 Mice Resemble Inclusions Identified in Multiple Sclerosis. Ultrastructural Pathology 23:5, pages 285-297.
Read now
Read now
Articles from other publishers (115)
Eriko Furube, Masahiro Ohgidani & Shigetaka Yoshida. (2023) Systemic Inflammation Leads to Changes in the Intracellular Localization of KLK6 in Oligodendrocytes in Spinal Cord White Matter. Neurochemical Research 48:9, pages 2645-2659.
Crossref
Crossref
Sarah A. Kent & Veronique E. Miron. (2023) Microglia regulation of central nervous system myelin health and regeneration. Nature Reviews Immunology.
Crossref
Crossref
Hiroaki Oizumi, Yuki Miyamoto, Chika Seiwa, Masahiro Yamamoto, Nozomu Yoshioka, Seiichi Iizuka, Tomohiro Torii, Katsuya Ohbuchi, Kazushige Mizoguchi, Junji Yamauchi & Hiroaki Asou. (2023) Lethal Adulthood Myelin Breakdown by Oligodendrocyte-specific Ddx54 Knockout. iScience, pages 107448.
Crossref
Crossref
Reza Rahmanzadeh, Matthias Weigel, Po-Jui Lu, Lester Melie-Garcia, Thanh D. Nguyen, Alessandro Cagol, Francesco La Rosa, Muhamed Barakovic, Antoine Lutti, Yi Wang, Meritxell Bach Cuadra, Ernst-Wilhelm Radue, Laura Gaetano, Ludwig Kappos, Jens Kuhle, Stefano Magon & Cristina Granziera. (2022) A comparative assessment of myelin-sensitive measures in multiple sclerosis patients and healthy subjects. NeuroImage: Clinical 36, pages 103177.
Crossref
Crossref
Bert A. ’t Hart, Antonio Luchicchi, Geert J. Schenk, Peter K. Stys & Jeroen J. G. Geurts. (2021) Mechanistic underpinning of an inside–out concept for autoimmunity in multiple sclerosis. Annals of Clinical and Translational Neurology 8:8, pages 1709-1719.
Crossref
Crossref
Antonio Luchicchi, Bert't Hart, Irene Frigerio, Anne‐Marie van Dam, Laura Perna, Herman L. Offerhaus, Peter K. Stys, Geert J. Schenk & Jeroen J. G. Geurts. (2021)
Axon‐Myelin Unit Blistering as Early Event in
MS
Normal Appearing White Matter
. Annals of Neurology 89:4, pages 711-725.
Crossref
Crossref
Talia Bergaglio, Antonio Luchicchi & Geert J. Schenk. (2021) Engine Failure in Axo-Myelinic Signaling: A Potential Key Player in the Pathogenesis of Multiple Sclerosis. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
B. Paul Morgan, Jennifer L. Gommerman & Valeria Ramaglia. (2021) An “Outside-In” and “Inside-Out” Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Vito Antonio Baldassarro, Alessandra Flagelli, Michele Sannia & Laura Calzà. 2021. Hormones and Stem Cells. Hormones and Stem Cells
389
407
.
Monokesh K. Sen, Mohammed S. M. Almuslehi, Peter J. Shortland, Jens R. Coorssen & David A. Mahns. (2020) Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?. Frontiers in Immunology 11.
Crossref
Crossref
Fatma ŞİMŞEK & Nurinnisa ÖZTÜRK. (2020) DCLK-1 LEVEL IN MULTIPLE SCLEROSIS PATIENTS AND ITS CORRELATION WITH CLINIC. Multiple Sclerosis and Related Disorders 43, pages 102179.
Crossref
Crossref
Charlotte G. H. M. de Jong, Hans-Joachim Gabius & Wia Baron. (2019) The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis. Cellular and Molecular Life Sciences 77:7, pages 1289-1317.
Crossref
Crossref
Stella Nyamoya, Julia Steinle, Uta Chrzanowski, Joel Kaye, Christoph Schmitz, Cordian Beyer & Markus Kipp. (2019) Laquinimod Supports Remyelination in Non-Supportive Environments. Cells 8:11, pages 1363.
Crossref
Crossref
Sen, Almuslehi, Gyengesi, Myers, Shortland, Mahns & Coorssen. (2019) Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis. Cells 8:11, pages 1314.
Crossref
Crossref
Tanja Hochstrasser, Sebastian Rühling, Kerstin Hecher, Kai H. Fabisch, Uta Chrzanowski, Matthias Brendel, Florian Eckenweber, Christian Sacher, Christoph Schmitz & Markus Kipp. (2019) Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination. Cells 8:9, pages 1024.
Crossref
Crossref
Reza Rahmanzadeh, Wolfgang Brück, Alireza Minagar & Mohammad Ali Sahraian. (2018) Multiple sclerosis pathogenesis: missing pieces of an old puzzle. Reviews in the Neurosciences 30:1, pages 67-83.
Crossref
Crossref
Shigeki Tsutsui. (2018) Studying the blood–brain barrier will provide new insights into neurodegeneration – No. Multiple Sclerosis Journal 24:8, pages 1025-1026.
Crossref
Crossref
Andrew V. Caprariello, James A. RogersMegan L. MorganVahid HoghooghiJason R. PlemelAdam Koebel, Shigeki TsutsuiJeffrey F. DunnLakshmi P. Kotra, Shalina S. OusmanV. Wee YongPeter K. Stys. (2018) Biochemically altered myelin triggers autoimmune demyelination. Proceedings of the National Academy of Sciences 115:21, pages 5528-5533.
Crossref
Crossref
Reza Rahmanzadeh, Mohammad Ali Sahraian, Ramin Rahmanzade & Moses Rodriguez. (2018) Demyelination with preferential MAG loss: A complex message from MS paraffin blocks. Journal of the Neurological Sciences 385, pages 126-130.
Crossref
Crossref
Yoshio Bando, Yoshiaki Hagiwara, Yasuhiro Suzuki, Kosuke Yoshida, Yoko Aburakawa, Takashi Kimura, Chisato Murakami, Miyuki Ono, Tatsuhide Tanaka, Ying-Ping Jiang, Branka Mitrovi, Hiroki Bochimoto, Osamu Yahara & Shigetaka Yoshida. (2018) Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis. Glia 66:2, pages 359-378.
Crossref
Crossref
Vijayaraghava T. S. Rao, Damla Khan, Qiao-Ling Cui, Shih-Chieh Fuh, Shireen Hossain, Guillermina Almazan, Gerhard Multhaup, Luke M. Healy, Timothy E. Kennedy & Jack P. Antel. (2017) Distinct age and differentiation-state dependent metabolic profiles of oligodendrocytes under optimal and stress conditions. PLOS ONE 12:8, pages e0182372.
Crossref
Crossref
Robert van den Berg, Casper C. Hoogenraad & Rogier Q. Hintzen. (2017) Axonal transport deficits in multiple sclerosis: spiraling into the abyss. Acta Neuropathologica 134:1, pages 1-14.
Crossref
Crossref
Qiao-Ling Cui, Damla Khan, Malena Rone, Vijayaraghava T.S. Rao, Radia Marie Johnson, Yun Hsuan Lin, Philippe-Antoine Bilodeau, Jeffery A. Hall, Moses Rodriguez, Timothy E. Kennedy, Samuel K. Ludwin & Jack P. Antel. (2017) Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?. Annals of Neurology 81:6, pages 811-824.
Crossref
Crossref
Markus Kipp, Stella Nyamoya, Tanja Hochstrasser & Sandra Amor. (2017) Multiple sclerosis animal models: a clinical and histopathological perspective. Brain Pathology 27:2, pages 123-137.
Crossref
Crossref
Stella Nyamoya, Felix Schweiger, Markus Kipp & Tanja Hochstrasser. (2017) Cuprizone as a model of myelin and axonal damage. Drug Discovery Today: Disease Models 25-26, pages 63-68.
Crossref
Crossref
Burcu Zeydan, Moses Rodriguez & Orhun H. Kantarci. 2017. Multiple Sclerosis: Bench to Bedside. Multiple Sclerosis: Bench to Bedside
161
170
.
Samuel K. Jensen & V. Wee Yong. (2016) Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis. Trends in Neurosciences 39:6, pages 356-365.
Crossref
Crossref
Melissa A. Lopes Pinheiro, Gijs Kooij, Mark R. Mizee, Alwin Kamermans, Gaby Enzmann, Ruth Lyck, Markus Schwaninger, Britta Engelhardt & Helga E. de Vries. (2016) Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:3, pages 461-471.
Crossref
Crossref
Bert A. 't Hart, Jordon Dunham, S. Anwar Jagessar & Yolanda S. Kap. (2016) The common marmoset (<i>Callithrix jacchus</i>): a relevant preclinical model of human (auto)immune-mediated inflammatory disease of the brain. Primate Biology 3:1, pages 9-22.
Crossref
Crossref
Miriam Scheld, Bernhard Josef Rüther, René Große-Veldmann, Kim Ohl, Klaus Tenbrock, Daniela Dreymüller, Petra Fallier-Becker, Adib Zendedel, Cordian Beyer, Tim Clarner & Markus Kipp. (2016) Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain. The Journal of Neuroscience 36:4, pages 1410-1415.
Crossref
Crossref
Maria Traka, Joseph R Podojil, Derrick P McCarthy, Stephen D Miller & Brian Popko. (2015) Oligodendrocyte death results in immune-mediated CNS demyelination. Nature Neuroscience 19:1, pages 65-74.
Crossref
Crossref
Brenda Huang, WenJie Wei, Guohao Wang, Marta A. Gaertig, Yue Feng, Wei Wang, Xiao-Jiang Li & Shihua Li. (2015) Mutant Huntingtin Downregulates Myelin Regulatory Factor-Mediated Myelin Gene Expression and Affects Mature Oligodendrocytes. Neuron 85:6, pages 1212-1226.
Crossref
Crossref
Barbara Maria Krauspe, Wolfgang Dreher, Cordian Beyer, Werner Baumgartner, Bernd Denecke, Katharina Janssen, Claus-Dieter Langhans, Tim Clarner & Markus Kipp. (2014) Short-Term Cuprizone Feeding Verifies N-Acetylaspartate Quantification as a Marker of Neurodegeneration. Journal of Molecular Neuroscience 55:3, pages 733-748.
Crossref
Crossref
Mithu Storoni & Gordon T. Plant. (2015) The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Multiple Sclerosis International 2015, pages 1-9.
Crossref
Crossref
Mikael Simons, Thomas Misgeld & Martin Kerschensteiner. (2014) A unified cell biological perspective on axon–myelin injury. Journal of Cell Biology 206:3, pages 335-345.
Crossref
Crossref
Robert A. Brown, Sridar Narayanan & Douglas L. Arnold. (2014) Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis. NeuroImage: Clinical 6, pages 20-25.
Crossref
Crossref
Abhijit Chaudhuri. (2013) Multiple sclerosis is primarily a neurodegenerative disease. Journal of Neural Transmission 120:10, pages 1463-1466.
Crossref
Crossref
Bogdan F. Gh. Popescu, Istvan Pirko & Claudia F. Lucchinetti. (2013) Pathology of Multiple Sclerosis. CONTINUUM: Lifelong Learning in Neurology 19, pages 901-921.
Crossref
Crossref
Elizabeth D. Buttermore, Courtney L. Thaxton & Manzoor A. Bhat. (2013) Organization and maintenance of molecular domains in myelinated axons. Journal of Neuroscience Research 91:5, pages 603-622.
Crossref
Crossref
Lars Bø, Margaret Esiri, Nikos Evangelou & Tanja Kuhlmann. 2013. Myelin Repair and Neuroprotection in Multiple Sclerosis. Myelin Repair and Neuroprotection in Multiple Sclerosis
23
45
.
Jilpa Patel & Roumen Balabanov. (2012) Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. International Journal of Molecular Sciences 13:8, pages 10647-10659.
Crossref
Crossref
Peter K. Stys, Gerald W. Zamponi, Jan van Minnen & Jeroen J. G. Geurts. (2012) Will the real multiple sclerosis please stand up?. Nature Reviews Neuroscience 13:7, pages 507-514.
Crossref
Crossref
M Kipp & S Amor. (2012) FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination. Multiple Sclerosis Journal 18:3, pages 258-263.
Crossref
Crossref
Marina A. Lynch & Kingston H.G. Mills. (2012) Immunology meets neuroscience – Opportunities for immune intervention in neurodegenerative diseases. Brain, Behavior, and Immunity 26:1, pages 1-10.
Crossref
Crossref
Xiaohua Xu, Arthur E. Warrington, Allan J. Bieber & Moses Rodriguez. (2011) Enhancing CNS Repair in Neurological Disease. CNS Drugs 25:7, pages 555-573.
Crossref
Crossref
I. N. Abdurasulova & V. M. Klimenko. (2011) Heterogeneity of the Mechanisms of Nerve Cell Damage in Demyelinating Autoimmune Diseases of the CNS. Neuroscience and Behavioral Physiology 41:4, pages 364-374.
Crossref
Crossref
Peter K. Stys. (2014) Multiple Sclerosis: Autoimmune Disease or Autoimmune Reaction?. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37:S2, pages S16-S23.
Crossref
Crossref
Sabah Mozafari, Mohammad Amin Sherafat, Mohammad Javan, Javad Mirnajafi-Zadeh & Taki Tiraihi. (2010) Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination. Brain Research 1351, pages 50-56.
Crossref
Crossref
Helmut Leitner. (2010) Influence of neurosteroids on the pathogenesis of multiple sclerosis. Medical Hypotheses 75:2, pages 229-234.
Crossref
Crossref
. 2016. Inflammatory Diseases of the Central Nervous System. Inflammatory Diseases of the Central Nervous System
47
124
.
Thomas Zeis, Alfonse Probst, Andreas Johann Steck, Christine Stadelmann, Wolfgang Brück & Nicole Schaeren‐Wiemers. (2009) Molecular Changes in White Matter Adjacent to an Active Demyelinating Lesion in Early Multiple Sclerosis. Brain Pathology 19:3, pages 459-466.
Crossref
Crossref
Courtney Thaxton & Manzoor A. Bhat. 2009. Cell Biology of the Axon. Cell Biology of the Axon
65
85
.
IB KezeleDL Arnold & DL Collins. (2008) Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions. Multiple Sclerosis Journal 14:6, pages 779-785.
Crossref
Crossref
F. Bistolfi. (2016) Extremely Low-Frequency Pulsed Magnetic Fields and Multiple Sclerosis: Effects on Neurotransmission Alone or Also on Immunomodulation? Building a Working Hypothesis. The Neuroradiology Journal 20:6, pages 676-693.
Crossref
Crossref
Claudia F. Lucchinetti. (2007) ADVANCES IN THE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS. CONTINUUM: Lifelong Learning in Neurology 13, pages 86-116.
Crossref
Crossref
Moses Rodriguez. (2007) Effectors of Demyelination and Remyelination in the CNS: Implications for Multiple Sclerosis. Brain Pathology 17:2, pages 219-229.
Crossref
Crossref
Richard H. Quarles. (2007) Myelin-associated glycoprotein (MAG): past, present and beyond. Journal of Neurochemistry 0:0, pages 070214184024009-???.
Crossref
Crossref
Claudia F. Lucchinetti. 2007. Immune Regulation and Immunotherapy in Autoimmune Disease. Immune Regulation and Immunotherapy in Autoimmune Disease
214
264
.
. 2006. McAlpine's Multiple Sclerosis. McAlpine's Multiple Sclerosis
811
946
.
Wolfgang Brück. (2005) Clinical implications of neuropathological findings in multiple sclerosis. Journal of Neurology 252:S3, pages iii10-iii14.
Crossref
Crossref
Claudia F. Lucchinetti, Joseph Parisi & Wolfgang Bruck. (2005) The pathology of multiple sclerosis. Neurologic Clinics 23:1, pages 77-105.
Crossref
Crossref
Alan D. Legatt. 2005. Electrodiagnosis in Clinical Neurology. Electrodiagnosis in Clinical Neurology
489
523
.
Andrzej Bacia, Robert Wollmann & Betty Soliven. (2004) K+ channel blockade impairs remyelination in the cuprizone model. Glia 48:2, pages 156-165.
Crossref
Crossref
Jaime Imitola, Evan Y. Snyder & Samia J. Khoury. (2003) Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis. Physiological Genomics 14:3, pages 171-197.
Crossref
Crossref
Claudia F. Lucchinetti, W. Brück & Hans Lassmann. 2003. Multiple Sclerosis 2. Multiple Sclerosis 2
93
113
.
M.Mateo Paz Soldán, Arthur E Warrington, Allan J Bieber, Bogoljub Ciric, Virginia Van Keulen, Larry R Pease & Moses Rodriguez. (2003) Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Molecular and Cellular Neuroscience 22:1, pages 14-24.
Crossref
Crossref
M. Mateo Paz Soldan & Moses Rodriguez. (2002) Heterogeneity of Pathogenesis in Multiple Sclerosis: Implications for Promotion of Remyelination. The Journal of Infectious Diseases 186:s2, pages S248-S253.
Crossref
Crossref
Hans Lassmann. (2002) Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clinical Neurology and Neurosurgery 104:3, pages 168-171.
Crossref
Crossref
T. Touil, M. S. A. Deloire-Grassin, C. Vital, K. G. Petry & B. Brochet. (2001) In vivo damage of CNS myelin and axons induced by peroxynitrite. Neuroreport 12:16, pages 3637-3644.
Crossref
Crossref
K Morgen, N O Jeffries, R Stone, R Martin, N D Richert, J A Frank & H F McFarland. (2016) Ring-enhancement in multiple sclerosis: marker of disease severity. Multiple Sclerosis Journal 7:3, pages 167-167.
Crossref
Crossref
Claudia Lucchinetti, Wolfgang Brück & John Noseworthy. (2001) Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Current Opinion in Neurology 14:3, pages 259-269.
Crossref
Crossref
Rana Zeine, Wendy Cammer, Elisa Barbarese, Chau‐Ching Liu & Cedric S. Raine. (2001) Structural dynamics of oligodendrocyte lysis by perforin in culture: Relevance to multiple sclerosis. Journal of Neuroscience Research 64:4, pages 380-391.
Crossref
Crossref
Dean M Wingerchuk, Claudia F Lucchinetti & John H Noseworthy. (2001) Multiple Sclerosis: Current Pathophysiological Concepts. Laboratory Investigation 81:3, pages 263-281.
Crossref
Crossref
T. Kuhlmann & W. Brück. 2001. Multiple Sklerose. Multiple Sklerose
11
17
.
Michael D. Weiss, Jeffrey Hammer & Richard H. Quarles. (2000) Oligodendrocytes in aging mice lacking myelin-associated glycoprotein are dystrophic but not apoptotic. Journal of Neuroscience Research 62:6, pages 772-780.
Crossref
Crossref
R. B. Banati, J. Newcombe, R. N. Gunn, A. Cagnin, F. Turkheimer, F. Heppner, G. Price, F. Wegner, G. Giovannoni, D. H. Miller, G. D. Perkin, T. Smith, A. K. Hewson, G. Bydder, G. W. Kreutzberg, T. Jones, M. L. Cuzner & R. Myers. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis. Brain 123:11, pages 2321-2337.
Crossref
Crossref
Claudia Lucchinetti, Wolfgang Br�ck, Joseph Parisi, Bernd Scheithauer, Moses Rodriguez & Hans Lassmann. (2000) Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Annals of Neurology 47:6, pages 707-717.
Crossref
Crossref
Melitta Schachner & Udo Bartsch. (2000) Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 29:2, pages 154-165.
Crossref
Crossref
Su-Chun Zhang & Ian D. Duncan. 2000. Functional Neural Transplantation II. Novel Cell Therapies For CNS Disorders. Functional Neural Transplantation II. Novel Cell Therapies For CNS Disorders
515
533
.
Guojun Zhao, David K.B. Li & Donald Paty. 2000. Brain Mapping: The Disorders. Brain Mapping: The Disorders
357
385
.
Claudia Lucchinetti, Wolfgang Brück, Joseph Parisi, Bernd Scheithauer, Moses Rodriguez & Hans Lassmann. (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. Brain 122:12, pages 2279-2295.
Crossref
Crossref
Merrill & Scolding. (2002) Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathology and Applied Neurobiology 25:6, pages 435-458.
Crossref
Crossref
M. RodriguezC.F. Lucchinetti. (1999) Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis?. Neurology 53:8, pages 1615-1615.
Crossref
Crossref
Eli Silber & Mohammad K Sharief. (1999) Axonal degeneration in the pathogenesis of multiple sclerosis. Journal of the Neurological Sciences 170:1, pages 11-18.
Crossref
Crossref
H. Lassmann. (1999) The pathology of multiple sclerosis and its evolution. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 354:1390, pages 1635-1640.
Crossref
Crossref
Bing Zhu, G.R.Wayne Moore, Thomas J. Zwimpfer, Lorne F. Kastrukoff, Jason K. Dyer, John D. Steeves, Donald W. Paty & Max S. Cynader. (1999) Axonal cytoskeleton changes in experimental optic neuritis. Brain Research 824:2, pages 204-217.
Crossref
Crossref
Dorian Mcgavern, Kunihiko Asakura & Moses Rodriquez. (2016) Do Antibodies Stimulate Myelin Repair in Multiple Sclerosis?. The Neuroscientist 5:1, pages 19-28.
Crossref
Crossref
B.H.J. Juurlink. (1998) The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infiltration are readily upregulated?. Medical Hypotheses 51:4, pages 299-303.
Crossref
Crossref
Lori L. Billinghurst, Rosanne M. Taylor & Evan Y. Snyder. (1998) Remyelination: Cellular and gene therapy. Seminars in Pediatric Neurology 5:3, pages 211-228.
Crossref
Crossref
Katerina Akassoglou, Jan Bauer, George Kassiotis, Manolis Pasparakis, Hans Lassmann, George Kollias & Lesley Probert. (1998) Oligodendrocyte Apoptosis and Primary Demyelination Induced by Local TNF/p55TNF Receptor Signaling in the Central Nervous System of Transgenic Mice. The American Journal of Pathology 153:3, pages 801-813.
Crossref
Crossref
Anthony T Reder, Kursad Genc, Paul V Byskosh & Anna Maria Porrini. (2016) Monocyte activation in multiple sclerosis. Multiple Sclerosis Journal 4:3, pages 162-168.
Crossref
Crossref
Kevin D. Pavelko, Baziel G. M. van Engelen & Moses Rodriguez. (1998) Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination. The Journal of Neuroscience 18:7, pages 2498-2505.
Crossref
Crossref
S. M. GreenbergJ.-P. G. VonsattelA. Z. SegalR. I. ChiuA. E. ClatworthyA. LiaoB. T. HymanG. W. Rebeck. (1998) Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50:4, pages 961-965.
Crossref
Crossref
Ponnada A. Narayana, Timothy J. Doyle, Dejian Lai & Jerry S. Wolinsky. (2004) Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Annals of Neurology 43:1, pages 56-71.
Crossref
Crossref
Claudia F. Lucchinetti & Moses Rodriguez. (1997) The Controversy Surrounding the Pathogenesis of the Multiple Sclerosis Lesion. Mayo Clinic Proceedings 72:7, pages 665-678.
Crossref
Crossref
Claudia F. Lucchinetti & Moses Rodriguez. (1997) The Controversy Surrounding the Pathogenesis of the Multiple Sclerosis Lesion. Mayo Clinic Proceedings 72:7, pages 665-678.
Crossref
Crossref
N. De Stefano, A. Federico & D. L. Arnold. (1997) Proton magnetic resonance spectroscopy in brain white matter disorders. The Italian Journal of Neurological Sciences 18:6, pages 331-339.
Crossref
Crossref
Baziel GM van Engelen, Kevin D Pavelko & Moses Rodriguez. (2016) Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination. Multiple Sclerosis Journal 3:2, pages 76-79.
Crossref
Crossref
CF Lucchinetti, JH Noseworthy & M. Rodriguez. (2016) Promotion of endogeneous remyelination in Multiple Sclerosis. Multiple Sclerosis Journal 3:2, pages 71-75.
Crossref
Crossref
S. Sriram & M. Rodriguez. (1997) Indictment of the microglia as the villain in multiple sclerosis. Neurology 48:2, pages 464-470.
Crossref
Crossref
Brian Popko, Joshua G. Corbin, Kristine D. Baerwald, Jeffrey Dupree & Annie M. Garcia. (1997) The effects of interferon-γ on the central nervous system. Molecular Neurobiology 14:1-2, pages 19-35.
Crossref
Crossref
Richard H. Quarles. (1997) Glycoproteins of myelin sheaths. Journal of Molecular Neuroscience 8:1, pages 1-12.
Crossref
Crossref
Hans LAssmann, Udo Bartsch, Dirk Montag & Melitta Schachner. (1997) Dying-back oligodendrogliopathy: A late sequel of myelin-associated glycoprotein deficiency. Glia 19:2, pages 104-110.
Crossref
Crossref
Kunihiko Asakura & Moses Rodriguez. 1997. Molecular Signaling and Regulation in Glial Cells. Molecular Signaling and Regulation in Glial Cells
297
311
.
D. L. Arnold, P. M. Matthews & N. De Stefano. 1997. Magnetic Resonance Spectroscopy and Imaging in Neurochemistry. Magnetic Resonance Spectroscopy and Imaging in Neurochemistry
267
288
.
David J. Miller, Kuni Asakura & Moses Rodriguez. (2008) Central Nervous System Remyelination Clinical Application of Basic Neuroscience Principles. Brain Pathology 6:3, pages 331-344.
Crossref
Crossref
Claudia F. Lucchinetti, Wolfgang Brück, Moses Rodriguez & Hans Lassmann. (2008) Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis. Brain Pathology 6:3, pages 259-274.
Crossref
Crossref
F.G. Mastronardi, A. Al-Sabbagh, P.A. Nelson, J. Rego, B.I. Roots & M.A. Moscarello. (1996) Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: Implications for demyelinating disease. Journal of Neuroscience Research 44:4, pages 344-349.
Crossref
Crossref
Moses Rodriguez, David J. Miller & Vanda A. Lennon. (1996) Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 46:2, pages 538-545.
Crossref
Crossref
J Kirk & A-L Zhou. (2018) Viral Infection at the Blood-Brain Barrier in Multiple Sclerosis: – An Ultrastructural Study of Tissues from a Uk Regional Brain Bank. Multiple Sclerosis Journal 1:4, pages 242-252.
Crossref
Crossref
Samuel F. Hunter & Moses Rodriguez. 1996. Immunoneurology. Immunoneurology
89
105
.
Zeynel A. Erkut, Michel A. Hofman, Rivka Ravid & Dick F. Swaab. (1995) Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis. Journal of Neuroimmunology 62:1, pages 27-33.
Crossref
Crossref
D. J. Miller, K. Asakura & M. Rodriguez. (2004) Experimental strategies to promote central nervous system remyelination in multiple sclerosis: Insights gained from the Theiler's virus model system. Journal of Neuroscience Research 41:3, pages 291-296.
Crossref
Crossref
B G van Engelen, D J Miller, K D Pavelko, O R Hommes & M Rodriguez. (1994) Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.. Journal of Neurology, Neurosurgery & Psychiatry 57:Suppl, pages 65-68.
Crossref
Crossref
Moses Rodriguez & David J. Miller. 1994. Neural Regeneration. Neural Regeneration
343
355
.